Boston Scientific Estimated Litigation Liability, Noncurrent decreased by 8.9% to $154.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 24.2%, from $124.00M to $154.00M. Over 4 years (FY 2020 to FY 2024), Estimated Litigation Liability, Noncurrent shows an upward trend with a 23.5% CAGR.
other_litigation_reserve_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00M | $191.00M | $284.00M | $230.00M | $155.00M | $130.00M | $212.00M | $209.00M | $210.00M | $161.00M | $172.00M | $154.00M | $133.00M | $124.00M | $149.00M | $180.00M | $169.00M | $154.00M |
| QoQ Change | — | -4.5% | +48.7% | -19.0% | -32.6% | -16.1% | +63.1% | -1.4% | +0.5% | -23.3% | +6.8% | -10.5% | -13.6% | -6.8% | +20.2% | +20.8% | -6.1% | -8.9% |
| YoY Change | — | — | — | — | -22.5% | -31.9% | -25.4% | -9.1% | +35.5% | +23.8% | -18.9% | -26.3% | -36.7% | -23.0% | -13.4% | +16.9% | +27.1% | +24.2% |